Aalia Khan - Department of Biosciences and Bioengineering, Indian Institute of Technology

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Correction: Novel Humanized CD19-CAR-T (now Talicabtagene Autoleucel, Tali-cel™) Cells in Relapsed/ Refractory Pediatric B-acute Lymphoblastic Leukemia- an Open-Label Single-Arm Phase-I/ib Study

Gaurav Narula, Swaminathan Keerthivasagam,Hasmukh Jain,Sachin Punatar,Akanksha Chichra,Chetan Dhamne,Prashant Tembhare,Papagudi Ganesan Subramanian,Nikhil Patkar,Minal Poojary,Anant Gokarn,Sumeet Mirgh,Nishant Jindal, Albeena Nisar, Deepali Pandit, Khushali Pandit,Alka Dwivedi,Atharva Karulkar, Ankesh Kumar Jaiswal,Aalia Khan, Shreshtha Shah,Afrin Rafiq, Moumita Basu,Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik,Nirmalya Roy Moulik,Shyam Srinivasan, Shilpushp Bhosle, Sumathi Hiregoudar, Shashank Ojha,Lingaraj Nayak,Jayshree Thorat,Bhausaheb Bagal,Manju Sengar,Navin Khattry,Shripad Banavali, Steven Highfill,Nirali N Shah,Rahul Purwar

Blood cancer journalno. 1 (2025): 98-98

Cited0Views0WOSNATUREBibtex

Talicabtagene Autoleucel for Relapsed or Refractory B-cell Malignancies: Results from an Open-Label, Multicentre, Phase 1/2 Study

Hasmukh Jain,Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Shreshtha Shah, Afrin Firfiray,Juber Pendhari, Ankesh Kumar Jaiswal,Aalia Khan, Manivasagam Sundharam, Anand Vaibhaw, Ashish Saroha, Shreewardhan Rajyopadhye, Moumita Basu, Sweety Asija, Ambalika Chowdhury, Rohit Beher, Ankit Banik,Alka Dwivedi, Shalini Purwar,Gaurav Narula,Shripad Banavali,Nitin Jain,Steven L Highfill,David Stroncek, Terry Fry, Sameer Melinkeri, Lovin Wilson, Narendra Agarwal, Anil Aribandi, Pavan Kumar Boyella,Nirali N Shah,Sattva S Neelapu,Manju Sengar,Rahul Purwar, CAR-T clinical trial group

The Lancet Haematology（2025）

Cited0Views0WOSBibtex

Development of a Novel Humanized BCMA-Directed CAR for Multiple Myeloma: Robust Activity and Low Toxicity in Preclinical Studies

Aalia N. Khan,Jayant S. Goda,Sweety Asija,Atharva Karulkar, Pranoti Palkar, Ambalika Chowdury, Ankesh K. Jaiswal, Deepti Phadnis,Shreshtha Shah,Afrin Firfiray,Juber Pendhari, Pranali Patil,Nirali N. Shah,Manju Sengar,Hasmukh Jain,Rahul Purwar

Bloodno. Supplement 1 (2024): 4809-4809

Cited0Views0Bibtex

CAR-T Cell Therapy in Hematological Malignancies: Where Are We Now and Where Are We Heading For

Aalia N. Khan,Sweety Asija,Juber Pendhari,Rahul Purwar

European journal of haematologyno. 1 (2023): 6-18

Cited9Views0WOSBibtex

Evaluating the Safety of HCAR19 (now Actalycabtagene Autoleucel- Actaly-Cel™), a Novel Humanized CD19-Directed Chimeric Antigen Receptor T-Cells in Pediatric, Adolescents, and Young Adults with Relapsed/ Refractory B- Acute Lymphoblastic Leukemia (ESHA) - Report of Phase-1B

BLOOD（2023）

Cited2Views0Bibtex

Immunogenicity of CAR-T Cell Therapeutics: Evidence, Mechanism and Mitigation

Aalia N. Khan, Ambalika Chowdhury,Atharva Karulkar,Ankesh Kumar Jaiswal,Ankit Banik,Sweety Asija,Rahul Purwar

Frontiers in immunology（2022）

Cited42Views0WOSBibtex

Phase I Trial of Humanized CD19 CART-Cell Therapy Developed in India: Safe, Active and Feasible for Outpatient Therapy

Blood（2022）

Cited2Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn